Patient Name : MANISH KUMAR (INDIA) DOB/Age : 21 years (Male)

Referral : SELF Reg. ID : 0908854444552

Registration Date : Feb 01, 2022, 09:05 a.m. Report Date : Feb 02, 2022, 08:55 a.m.
Source : WEST DELHI Sample ID :

National Identity No : - WD09038524

Nationality : Indian

Test Description Value(s) Reference Range

SARS-COV-2 Real-Time PCR, Qualitative

COVID-19 Virus Qualitative PCR

Specimen: Nasopharyngeal and Oropharyngeal swabs

RESULT: NEGATIVE

INTERPRETATION:
Result Interpretation

Positive RNA Specific to SARS-CoV-2 Detected

Negative RNA Specific to SARS-CoV-2 Not Detected

Inconclusive A repeat test on fresh sample is recommended

NOTE:
1. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations and insufficient RNA specific
to SARS-CoV-2 can influence the test result. Kindly correlate the result with clinical findings.
2. Test conducted as per Kit approved by ICMR.
3. Target Genes RdRP, N gene, S gene, E gene and RNaseP.
4. Kindly consult referring Physician/Authority Govt. hospital and correlate clinically.
5. ICMR Registration number for Covid-19 is GDCLD.
6. Strategy for COVID19 testing in India (Version 5, dated 18/05/2020)
• All symptomatic (ILI symptoms) individuals with history of international travel in the last 14 days.
• All symptomatic (ILI symptoms) contacts of laboratory confirmed cases.
• All symptomatic (ILI symptoms) health care workers / frontline workers involved in containment and mitigation of COVID19.
• All patients of Severe Acute Respiratory Infection (SARI).

Scan to validate
 Patient Name : MANISH KUMAR (INDIA) DOB/Age : 21 years (Male)
Referral : SELF Reg. ID : 0908854444552
Registration Date : Feb 01, 2022, 09:05 a.m. Report Date : Feb 02, 2022, 08:55 a.m.
Source : WEST DELHI Sample ID :

National Identity No : - WD09038524

Nationality : Indian

Test Description Value(s) Reference Range

• Asymptomatic direct and high-risk contacts of a confirmed case to be tested once between day 5 and day 10 of coming into contact.
• All symptomatic ILI within hotspots/containment zones.
• All hospitalized patients who develop ILI symptoms.
• All symptomatic ILI among returnees and migrants within 7 days of illness.
• No emergency procedure (including deliveries) should be delayed for lack of test. However, sample can be sent for testing if indicated as
above (1-8), simultaneously.

**END OF REPORT**

Scan to validate